Developer docs
API playgroundTry for free, no card

Search company profiles

Fore Genomics

Full company profile

uuid0008c7f

Namestring
Fore Genomics
Legal namestring
Fore Genomics, Inc.
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Fore Genomics, Inc., a private US company headquartered in San Diego and founded in 2020 by CEO Matt Pelo, sells direct-to-consumer pediatric genetic screening. Its single core product, the At-Home Pediatric Genetic Health Screen, uses whole genome sequencing on a cheek-swab sample to screen for over 1,000 pediatric-onset conditions and 100+ medication sensitivities, with processing in CLIA-certified and CAP-accredited labs and storage on the DNAnexus platform (ISO 27001, HIPAA, GDPR, FedRAMP Moderate, CSA STAR Level 2). Results are delivered through a secure digital portal and accompanied by board-certified genetic counselor consultations, with annual re-analysis of the same sample as the scientific literature evolves.

The product is priced at $495 as a one-time purchase covering the kit, sequencing, counseling, and encrypted storage. Revenue mechanics blend a one-time transactional sale with a recurring annual re-analysis subscription, plus gift card SKUs ($100, $250, $495) that enable gifting. Go-to-market is self-serve e-commerce on a Shopify-style storefront with content-led demand generation across blog, case studies, organic social, and email capture; HSA/FSA eligibility and BBB accreditation support consumer trust. Strategic technology and go-to-market partners include DNAnexus (infrastructure), Inocras, DNA Ally, Grey Genetics (partner logos), and Celebration Stem Cell Centre (cord-blood-banking cross-sell).

The company is early-stage and bootstrapped, with no disclosed external funding and a 1-10 employee footprint including a CTO, CCO (PharmD), VP Product, VP Marketing, and Head of Growth. Customer concentration is by design diffuse, given a pure long-tail DTC consumer model, and named customers are individual families. Revenue, customer count, and growth metrics are not disclosed in the available data.

Short descriptiontext

Fore Genomics is a private San Diego company selling a $495 at-home whole-genome-sequencing pediatric genetic health screen to US parents, covering 1,000+ conditions and medication sensitivities via a DTC e-commerce model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLa Jolla, United States
HQ citystring
La Jolla
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pediatric genetic screening, whole genome sequencing, at-home DNA testing, pharmacogenomic screening, genetic health diagnostics
Industry5 codes
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAJAIAJ
Newborn Screening & Genetic Public Health Laboratories
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Pediatric Genetic Screening
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1At-Home Pediatric Genetic Health Screen
TypeOne Time License
Description

One-time purchase of genetic screening kit at $495, includes whole genome sequencing, 1,000+ condition screening, 100+ medication sensitivity indicators, access to board-certified genetic counselors, and encrypted data storage

foregenomics.com
2Annual Updates
TypeSubscription Recurring
Description

Annual re-analysis of existing genome sample as new scientific discoveries emerge, providing updated reports

foregenomics.com
3Gift Cards
TypeOne Time License
Description

Prepaid gift cards available in $100, $250, and $495 denominations for gifting the screening service

foregenomics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1At-Home Pediatric Genetic Health Screen - $495
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Comprehensive package includes: 1 cheek swab & specimen collection vial, 1,000+ clinically actionable pediatric-onset conditions, 100+ medication sensitivity indicators, access to board-certified genetic counselors, clinical results from CLIA/CAP accredited labs, personalized clinical reports, provider-ready clinical care plans, fully encrypted data storage. Results typically available in about 4 weeks.

foregenomics.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Fore Genomics sells a direct-to-consumer At-Home Pediatric Genetic Health Screen ($495) that uses whole genome sequencing on a self-collected cheek swab to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivities, with results delivered through a secure digital portal and board-certified genetic counselor consultation. The service includes annual re-analysis of the stored genome as new scientific discoveries emerge, and is supported by CLIA/CAP-accredited lab processing and HIPAA-compliant encrypted data storage.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Nearly 10% of pediatric hospital admissions are due to adverse drug reactions - Fore's pharmacogenomics testing can help reduce this risk
+2 more records
Product overview1 text field

Fore Genomics offers a single unified product—the At-Home Pediatric Genetic Health Screen—which uses whole genome sequencing (WGS) to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivities from an at-home cheek swab. The service is priced at $495 and includes sample collection kit, CLIA/CAP accredited lab processing, secure digital results portal, genetic counselor consultation, and annual re-analysis updates. The company also offers Gift Cards in $100, $250, and $495 denominations for gifting the screening service.

Product and service2 records
1At-Home Pediatric Genetic Health Screen
CategoryPediatric Genetic Screening Service
Description

A direct-to-consumer, at-home genetic screening service that uses whole genome sequencing on a self-collected cheek swab to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivity indicators. Includes CLIA/CAP-accredited lab processing, secure digital results portal, board-certified genetic counselor consultation, physician-ready clinical reports, and annual re-analysis of the stored genome as new science emerges; intended for parents seeking proactive preventive healthcare for newborns and young children.

2Fore Genomics Gift Card
CategoryGift Card
Description

A prepaid digital gift card redeemable on the Fore Genomics website for the At-Home Pediatric Genetic Health Screen. Available in $100, $250, and $495 denominations and used by customers purchasing the screening as a gift for another family.

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

DNAnexus is Fore Genomics' primary data storage and management partner. The platform is trusted by leading hospitals and research institutions worldwide. DNAnexus maintains rigorous compliance with ISO 27001, HIPAA, GDPR, and NIST 800 standards including FedRAMP Moderate Authorization. All genetic data is encrypted and stored in high-security facilities under strict access controls.

2Celebration Stem Cell Centre
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Celebration Stem Cell Centre partnered with Fore Genomics to offer pediatric genetic screening services alongside cord blood banking. This partnership provides families with a combined approach of genetic insight and stem cell preservation for future therapeutic options.

foregenomics.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Once the dominant DTC genetic testing brand; Fore competes in the same direct-to-consumer DNA test category with at-home saliva/swab collection and online results, though Fore is pediatric-focused and uses whole genome sequencing rather than genotyping arrays.

TypeEmerging player
Description

DTC-adjacent clinical genetic testing company with hereditary cancer, PGx, and population genomics offerings; competes with Fore on the proactive health testing concept and on pharmacogenomics, with stronger enterprise and employer channels.

TypeDirect peer
Description

DTC whole genome sequencing company offering at-home WGS with deep-coverage analysis and optional ongoing insights — closest direct competitor to Fore on the WGS-plus-ongoing-reanalysis value proposition.

TypeEmerging player
Description

Clinical genomics lab specializing in whole genome sequencing for rare disease diagnostics; comparable to Fore on the WGS technology stack and pediatric/rare-disease focus, but operating in the provider-ordered channel.

TypeBroad incumbent
Description

Established clinical genetic testing lab with pediatric and reproductive health offerings including pharmacogenomics; a broader incumbent in the same clinical genetic testing space where Fore operates its pediatric-focused niche.

TypeRegional player
Description

DTC and clinical genetic testing company in India offering whole genome and panels for proactive health; comparable business model to Fore (DTC, at-home, health-focused) but primarily serving a different geography.

TypeBroad incumbent
Description

Long-established clinical genetic testing company with a broad menu including hereditary cancer, pharmacogenomics, and rare disease panels; overlaps with Fore in the genetic and pharmacogenomic testing layer at a much larger, provider-channel scale.

8PerkinElmer Genomics
TypeBroad incumbent
Description

Clinical genomics and newborn screening services business of a large life-sciences tools company; direct overlap with Fore on the pediatric and newborn screening category, accessed primarily through clinicians and state public health programs.

TypeBroad incumbent
Description

Clinical genomics laboratory offering pediatric and rare disease whole genome and exome sequencing ordered through healthcare providers; competes with Fore on the pediatric clinical genomics content but accesses customers via clinicians rather than DTC.

TypeEmerging player
Description

Population genomics and clinical sequencing company operating a CLIA/CAP lab with a marketplace of DNA-powered apps; overlaps with Fore in the whole-exome/genome clinical infrastructure and in serving consumers through digital results.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fore Genomics

Pediatric Genetic Screeningforegenomics.com

Fore Genomics is a private San Diego company selling a $495 at-home whole-genome-sequencing pediatric genetic health screen to US parents, covering 1,000+ conditions and medication sensitivities via a DTC e-commerce model.

What Fore Genomics does

Fore Genomics, Inc., a private US company headquartered in San Diego and founded in 2020 by CEO Matt Pelo, sells direct-to-consumer pediatric genetic screening. Its single core product, the At-Home Pediatric Genetic Health Screen, uses whole genome sequencing on a cheek-swab sample to screen for over 1,000 pediatric-onset conditions and 100+ medication sensitivities, with processing in CLIA-certified and CAP-accredited labs and storage on the DNAnexus platform (ISO 27001, HIPAA, GDPR, FedRAMP Moderate, CSA STAR Level 2). Results are delivered through a secure digital portal and accompanied by board-certified genetic counselor consultations, with annual re-analysis of the same sample as the scientific literature evolves.

The product is priced at $495 as a one-time purchase covering the kit, sequencing, counseling, and encrypted storage. Revenue mechanics blend a one-time transactional sale with a recurring annual re-analysis subscription, plus gift card SKUs ($100, $250, $495) that enable gifting. Go-to-market is self-serve e-commerce on a Shopify-style storefront with content-led demand generation across blog, case studies, organic social, and email capture; HSA/FSA eligibility and BBB accreditation support consumer trust. Strategic technology and go-to-market partners include DNAnexus (infrastructure), Inocras, DNA Ally, Grey Genetics (partner logos), and Celebration Stem Cell Centre (cord-blood-banking cross-sell).

The company is early-stage and bootstrapped, with no disclosed external funding and a 1-10 employee footprint including a CTO, CCO (PharmD), VP Product, VP Marketing, and Head of Growth. Customer concentration is by design diffuse, given a pure long-tail DTC consumer model, and named customers are individual families. Revenue, customer count, and growth metrics are not disclosed in the available data.

Fore Genomics firmographics

Firmographics
Name
Fore Genomics
Legal name
Fore Genomics, Inc.
Website
https://foregenomics.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Fore Genomics is a private San Diego company selling a $495 at-home whole-genome-sequencing pediatric genetic health screen to US parents, covering 1,000+ conditions and medication sensitivities via a DTC e-commerce model.
Ownership category
akta.pro rank

Fore Genomics industry classification

Industry
Product category
Pediatric Genetic Screening
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAJAIAJ
Newborn Screening & Genetic Public Health Laboratories
Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Pediatric genetic screening
  • Whole genome sequencing
  • At-home DNA testing
  • Pharmacogenomic screening
  • Genetic health diagnostics

Where Fore Genomics is headquartered

Location

Headquarters

HQ city
La Jolla
HQ country
United States
HQ region
North America

Markets served

Fore Genomics business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. At-Home Pediatric Genetic Health Screen: One-time purchase of genetic screening kit at $495, includes whole genome sequencing, 1,000+ condition screening, 100+ medication sensitivity indicators, access to board-certified genetic counselors, and encrypted data storage
  2. Annual Updates: Annual re-analysis of existing genome sample as new scientific discoveries emerge, providing updated reports
  3. Gift Cards: Prepaid gift cards available in $100, $250, and $495 denominations for gifting the screening service

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goAt-Home Pediatric Genetic Health Screen - $495

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Fore Genomics product offering

Product offering

Core offering

Fore Genomics sells a direct-to-consumer At-Home Pediatric Genetic Health Screen ($495) that uses whole genome sequencing on a self-collected cheek swab to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivities, with results delivered through a secure digital portal and board-certified genetic counselor consultation. The service includes annual re-analysis of the stored genome as new scientific discoveries emerge, and is supported by CLIA/CAP-accredited lab processing and HIPAA-compliant encrypted data storage.

Product overview

Fore Genomics offers a single unified product—the At-Home Pediatric Genetic Health Screen—which uses whole genome sequencing (WGS) to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivities from an at-home cheek swab. The service is priced at $495 and includes sample collection kit, CLIA/CAP accredited lab processing, secure digital results portal, genetic counselor consultation, and annual re-analysis updates. The company also offers Gift Cards in $100, $250, and $495 denominations for gifting the screening service.

Differentiator

Problem solved

Functional benefit

Products and services

  • At-Home Pediatric Genetic Health Screen A direct-to-consumer, at-home genetic screening service that uses whole genome sequencing on a self-collected cheek swab to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivity indicators. Includes CLIA/CAP-accredited lab processing, secure digital results portal, board-certified genetic counselor consultation, physician-ready clinical reports, and annual re-analysis of the stored genome as new science emerges; intended for parents seeking proactive preventive healthcare for newborns and young children.
  • Fore Genomics Gift Card A prepaid digital gift card redeemable on the Fore Genomics website for the At-Home Pediatric Genetic Health Screen. Available in $100, $250, and $495 denominations and used by customers purchasing the screening as a gift for another family.

Quantifiable outcome

  • Nearly 10% of pediatric hospital admissions are due to adverse drug reactions - Fore's pharmacogenomics testing can help reduce this risk
  • +2 more outcomes

Companies that use Fore Genomics

Customer profile

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Fore Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Fore Genomics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • DNAnexuscoreTechnology or IntegrationDNAnexus is Fore Genomics' primary data storage and management partner. The platform is trusted by leading hospitals and research institutions worldwide. DNAnexus maintains rigorous compliance with ISO 27001, HIPAA, GDPR, and NIST 800 standards including FedRAMP Moderate Authorization. All genetic data is encrypted and stored in high-security facilities under strict access controls.
  • Celebration Stem Cell CentreminorStrategic or Co-development PartnerCelebration Stem Cell Centre partnered with Fore Genomics to offer pediatric genetic screening services alongside cord blood banking. This partnership provides families with a combined approach of genetic insight and stem cell preservation for future therapeutic options.

Recent moves6 records

Expansion highlights6 records

Fore Genomics competitors and assessment

Company assessment

Direct peers

  • 23andMe: Once the dominant DTC genetic testing brand; Fore competes in the same direct-to-consumer DNA test category with at-home saliva/swab collection and online results, though Fore is pediatric-focused and uses whole genome sequencing rather than genotyping arrays.
  • Nebula Genomics: DTC whole genome sequencing company offering at-home WGS with deep-coverage analysis and optional ongoing insights — closest direct competitor to Fore on the WGS-plus-ongoing-reanalysis value proposition.

Emerging players

  • Color Health: DTC-adjacent clinical genetic testing company with hereditary cancer, PGx, and population genomics offerings; competes with Fore on the proactive health testing concept and on pharmacogenomics, with stronger enterprise and employer channels.
  • Variantyx: Clinical genomics lab specializing in whole genome sequencing for rare disease diagnostics; comparable to Fore on the WGS technology stack and pediatric/rare-disease focus, but operating in the provider-ordered channel.
  • Helix: Population genomics and clinical sequencing company operating a CLIA/CAP lab with a marketplace of DNA-powered apps; overlaps with Fore in the whole-exome/genome clinical infrastructure and in serving consumers through digital results.

Broad incumbents

  • Natera: Established clinical genetic testing lab with pediatric and reproductive health offerings including pharmacogenomics; a broader incumbent in the same clinical genetic testing space where Fore operates its pediatric-focused niche.
  • Myriad Genetics: Long-established clinical genetic testing company with a broad menu including hereditary cancer, pharmacogenomics, and rare disease panels; overlaps with Fore in the genetic and pharmacogenomic testing layer at a much larger, provider-channel scale.
  • PerkinElmer Genomics: Clinical genomics and newborn screening services business of a large life-sciences tools company; direct overlap with Fore on the pediatric and newborn screening category, accessed primarily through clinicians and state public health programs.
  • GeneDx (formerly Sema4): Clinical genomics laboratory offering pediatric and rare disease whole genome and exome sequencing ordered through healthcare providers; competes with Fore on the pediatric clinical genomics content but accesses customers via clinicians rather than DTC.

Regional players

  • Mapmygenome: DTC and clinical genetic testing company in India offering whole genome and panels for proactive health; comparable business model to Fore (DTC, at-home, health-focused) but primarily serving a different geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Fore Genomics social profiles

Digital presence

Fore Genomics compliance and trust

Trust signal

Compliance6 records

Fore Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fore Genomics leadership team

Management profile

Number of profiles

Profiles6 records

Fore Genomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fore Genomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fore Genomics

What does Fore Genomics do?

Fore Genomics sells a direct-to-consumer At-Home Pediatric Genetic Health Screen ($495) that uses whole genome sequencing on a self-collected cheek swab to screen for over 1,000 pediatric-onset genetic conditions and 100+ medication sensitivities, with results delivered through a secure digital portal and board-certified genetic counselor consultation. The service includes annual re-analysis of the stored genome as new scientific discoveries emerge, and is supported by CLIA/CAP-accredited lab processing and HIPAA-compliant encrypted data storage.

Is Fore Genomics a public or private company?

Fore Genomics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Fore Genomics founded?

Fore Genomics was founded in 2021. It employs 1 to 10 people.

Where is Fore Genomics based?

Fore Genomics is headquartered in La Jolla, United States, in the North America region.

How does Fore Genomics make money?

Three revenue lines are on record. At-Home Pediatric Genetic Health Screen is the primary driver. The others are annual Updates and gift Cards.

Who are Fore Genomics's main competitors?

Direct peers on record are 23andMe and Nebula Genomics. Emerging players are Color Health, Variantyx and Helix. Broad incumbents are Natera, Myriad Genetics, PerkinElmer Genomics and GeneDx (formerly Sema4). Mapmygenome is listed as a regional player.

Does Fore Genomics have an API?

No public API is recorded for Fore Genomics.

What industry is Fore Genomics in?

Fore Genomics's product category is Pediatric Genetic Screening. Its primary akta.pro industry code is HLAFAMAH, Genetic & Prenatal Testing Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals